<html>
<head>PUBMED IDs for NANOGP8</head>
<body bgcolor='#C5F0F2'><h1>NANOGP8</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16623708/'>NANOGP8 is a retrogene expressed in cancers.</a> April 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19415763/'>Functional evidence that the self-renewal gene NANOG regulates human tumor development.</a> July 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22966326/'>The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development.</a> May 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21136380/'>Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.</a> September 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21499299/'>NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.</a> November 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22216200/'>Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.</a> May 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22216197/'>The Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxia.</a> May 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22252524/'>Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.</a> October 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22851508/'>Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms.</a> February 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23085761/'>NANOG modulates stemness in human colorectal cancer.</a> November 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23173096/'>NANOGP8: evolution of a human-specific retro-oncogene.</a> April 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23683786/'>RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway.</a> October 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23752184/'>Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer.</a> June 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24318967/'>Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.</a> March 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24762991/'>[Expression of NANOG gene in acute lymphoblastic leukemia cells and construction of lentiviral vector carrying NANOG specific shRNA].</a> September 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25208882/'>Inhibition of NANOG/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics.</a> July 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26087476/'>CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.</a> September 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28345785/'>NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades.</a> March 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28345770/'>Effect of 1,25(OH)2 D3 and 20(OH)D3 on interleukin-1Î²-stimulated interleukin-6 and -8 production by human gingival fibroblasts.</a> March 28  2017<br></body></html>
